{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:42:42Z","timestamp":1740145362089,"version":"3.37.3"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Polish Ministry of Science and Higher Education","award":["ST.B130.16.049","STM.B131.17.008"],"award-info":[{"award-number":["ST.B130.16.049","STM.B131.17.008"]}]},{"DOI":"10.13039\/501100004442","name":"National Science Centre","doi-asserted-by":"crossref","award":["2016\/21\/B\/ST6\/02176"],"award-info":[{"award-number":["2016\/21\/B\/ST6\/02176"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","translationalres.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.trsl.2018.09.002","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T03:55:23Z","timestamp":1538020523000},"page":"72-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["SMAD7 is a novel independent predictor of survival in patients with cutaneous melanoma"],"prefix":"10.1016","volume":"204","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7787-9952","authenticated-orcid":false,"given":"Maciej","family":"Kaczorowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Przemyslaw","family":"Biecek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Donizy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malgorzata","family":"Pieniazek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafal","family":"Matkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Halon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2018.09.002_bib0001","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","article-title":"TGFbeta in cancer","volume":"134","author":"Massague","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2018.09.002_bib0002","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2741\/3986","article-title":"Alterations in the Smad pathway in human cancers","volume":"17","author":"Samanta","year":"2012","journal-title":"Front Biosci"},{"key":"10.1016\/j.trsl.2018.09.002_bib0003","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1126\/science.7761852","article-title":"Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability","volume":"268","author":"Markowitz","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.trsl.2018.09.002_bib0004","first-page":"4679","article-title":"Transforming growth factor-beta receptor type I gene is frequently mutated in ovarian carcinomas","volume":"61","author":"Chen","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2018.09.002_bib0005","first-page":"4227","article-title":"Mutational analysis of the transforming growth factor beta receptor type II gene in human ovarian carcinoma","volume":"58","author":"Lynch","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2018.09.002_bib0006","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ygyno.2005.04.031","article-title":"Aberrant expression and mutations of TGF-beta receptor type II gene in endometrial cancer","volume":"98","author":"Sakaguchi","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.trsl.2018.09.002_bib0007","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1126\/science.271.5247.350","article-title":"DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1","volume":"271","author":"Hahn","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.trsl.2018.09.002_bib0008","doi-asserted-by":"crossref","first-page":"12477","DOI":"10.1074\/jbc.C100008200","article-title":"Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation","volume":"276","author":"Ebisawa","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2018.09.002_bib0009","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S1097-2765(00)00134-9","article-title":"Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation","volume":"6","author":"Kavsak","year":"2000","journal-title":"Mol Cell"},{"key":"10.1016\/j.trsl.2018.09.002_bib0010","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1083\/jcb.200307151","article-title":"GADD34-PP1c recruited by Smad7 dephosphorylates TGFbeta type I receptor","volume":"164","author":"Shi","year":"2004","journal-title":"J Cell Biol"},{"key":"10.1016\/j.trsl.2018.09.002_bib0011","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/BF03345213","article-title":"Expression of Smad4 and Smad7 in human thyroid follicular carcinoma cell lines","volume":"26","author":"Cerutti","year":"2003","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.trsl.2018.09.002_bib0012","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.yexmp.2009.03.003","article-title":"Smad4\/Smad7 balance: a role of tumorigenesis in gastric cancer","volume":"87","author":"Leng","year":"2009","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.trsl.2018.09.002_bib0013","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1600-0463.2011.02814.x","article-title":"Differential effect of the expression of TGF-beta pathway inhibitors, Smad-7 and Ski, on invasive breast carcinomas: relation to biologic behavior","volume":"120","author":"Theohari","year":"2012","journal-title":"APMIS"},{"key":"10.1016\/j.trsl.2018.09.002_bib0014","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ijc.10908","article-title":"SMAD7 is a prognostic marker in patients with colorectal cancer","volume":"104","author":"Boulay","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.trsl.2018.09.002_bib0015","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/annonc\/mdh131","article-title":"Prognostic significance of the expression of Smad4 and Smad7 in human gastric carcinomas","volume":"15","author":"Kim","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.trsl.2018.09.002_bib0016","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ygyno.2004.10.006","article-title":"Overexpression of the TGF-beta antagonist Smad7 in endometrial cancer","volume":"96","author":"Dowdy","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.trsl.2018.09.002_bib0017","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1245\/s10434-008-0284-5","article-title":"Low-level expression of Smad7 correlates with lymph node metastasis and poor prognosis in patients with pancreatic cancer","volume":"16","author":"Wang","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.trsl.2018.09.002_bib0018","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/hep.26369","article-title":"MicroRNA-216a\/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer","volume":"58","author":"Xia","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2018.09.002_bib0019","doi-asserted-by":"crossref","first-page":"7624","DOI":"10.1038\/sj.onc.1208900","article-title":"Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo","volume":"24","author":"Javelaud","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.trsl.2018.09.002_bib0020","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1158\/0008-5472.CAN-06-3950","article-title":"Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis","volume":"67","author":"Javelaud","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2018.09.002_bib0021","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1755-148X.2010.00758.x","article-title":"Smad7 restricts melanoma invasion by restoring N-cadherin expression and establishing heterotypic cell-cell interactions in vivo","volume":"23","author":"DiVito","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.trsl.2018.09.002_bib0022","first-page":"138","article-title":"Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue","volume":"8","author":"Remmele","year":"1987","journal-title":"Pathologe"},{"key":"10.1016\/j.trsl.2018.09.002_bib0023","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1073\/pnas.0508977103","article-title":"In vivo disruption of TGF-beta signaling by Smad7 leads to premalignant ductal lesions in the pancreas","volume":"103","author":"Kuang","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2018.09.002_bib0024","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.yexcr.2005.03.009","article-title":"Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis","volume":"307","author":"Halder","year":"2005","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.trsl.2018.09.002_bib0025","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1038\/sj.onc.1202909","article-title":"The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer","volume":"18","author":"Kleeff","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.trsl.2018.09.002_bib0026","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/39369","article-title":"Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling","volume":"389","author":"Nakao","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2018.09.002_bib0027","first-page":"1887","article-title":"Melanoma-associated expression of transforming growth factor-beta isoforms","volume":"148","author":"Van Belle","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2018.09.002_bib0028","first-page":"97","article-title":"Expression of transforming growth factor-beta 2 in malignant melanoma correlates with the depth of tumor invasion. Implications for tumor progression","volume":"145","author":"Reed","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2018.09.002_bib0029","doi-asserted-by":"crossref","first-page":"10498","DOI":"10.18632\/oncotarget.14443","article-title":"Investigating the utility of human melanoma cell lines as tumour models","volume":"8","author":"Vincent","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.trsl.2018.09.002_bib0030","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.cellsig.2012.10.011","article-title":"TGF-beta inhibits human cutaneous melanoma cell migration and invasion through regulation of the plasminogen activator system","volume":"25","author":"Humbert","year":"2013","journal-title":"Cell Signal"},{"key":"10.1016\/j.trsl.2018.09.002_bib0031","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/exd.12629","article-title":"Role of IL-10 and TGF-beta in melanoma","volume":"24","author":"Wiguna","year":"2015","journal-title":"Exp Dermatol"},{"issue":"D1","key":"10.1016\/j.trsl.2018.09.002_bib0032","doi-asserted-by":"crossref","first-page":"D560","DOI":"10.1093\/nar\/gkv1337","article-title":"MERAV: a tool for comparing gene expression across human tissues and cell types","volume":"44","author":"Shaul","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.trsl.2018.09.002_bib0033","doi-asserted-by":"crossref","first-page":"10113","DOI":"10.1073\/pnas.1705755114","article-title":"Smad7 enables STAT3 activation and promotes pluripotency independent of TGF-beta signaling","volume":"114","author":"Yu","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2018.09.002_bib0034","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10555-005-1580-1","article-title":"Targeting STAT3 affects melanoma on multiple fronts","volume":"24","author":"Kortylewski","year":"2005","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.trsl.2018.09.002_bib0035","doi-asserted-by":"crossref","first-page":"21858","DOI":"10.1074\/jbc.M500583200","article-title":"Smad7 abrogates transforming growth factor-beta1-mediated growth inhibition in COLO-357 cells through functional inactivation of the retinoblastoma protein","volume":"280","author":"Boyer Arnold","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2018.09.002_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20101827","article-title":"Smad7: not only a regulator, but also a cross-talk mediator of TGF-beta signalling","volume":"434","author":"Yan","year":"2011","journal-title":"Biochem J"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524418301798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524418301798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T08:41:58Z","timestamp":1547023318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524418301798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":36,"alternative-id":["S1931524418301798"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2018.09.002","relation":{},"ISSN":["1931-5244"],"issn-type":[{"type":"print","value":"1931-5244"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SMAD7 is a novel independent predictor of survival in patients with cutaneous melanoma","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2018.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}